Founded in 1998, Emergent BioSolutions’s history has been one of innovation and growth. It stays true to its mission: to protect and enhance life.
Emergent is a manufacturer of the only FDA-approved anthrax vaccine, BioThrax, and is a major supplier to the US government. This has enabled the company to expand into other therapeutic areas.
In 2014, Emergent acquired Cangene Corporation, bringing over 70 years of experience in researching and marketing to the company. These new skills gave Emergent a better understanding of lifesaving therapies for treatment of rare diseases, blood disorders, and medical countermeasures for biodefense.